TABLE 1.
Disease | Pathogen | Type of pathogen | Association with disease processes |
Alzheimer’s disease (AD) | Chlamydia pneumoniae | Gram-negative bacteria | • Detected in post-mortem brains and brain tissue samples of AD patients (Balin et al., 1998; Gérard et al., 2006) • Upregulated β and γ secretase in infected astrocytes, promoted Aβ peptide formation in vitro(Al-Atrache et al., 2019) |
Porphyromonas gingivalis | Gram-negative bacteria | • Detected in the brains and biofluids of AD patients (Poole et al., 2013; Dominy et al., 2019) • Increased production of TNF-α, IL-6, and IL-1β in mice (Ding et al., 2018; PMID: Ilievski et al., 2018) • Increased Aβ peptide accumulation in the brain of infected or PgLPS-treated mice (Wu et al., 2017; Ilievski et al., 2018) |
|
Salmonella typhimurium | Gram-negative bacteria | • Increased Aβ peptide deposition in the brain of infected mice to bind and entrap bacteria (Kumar et al., 2016) | |
Human herpesvirus 6A (HHV-6A) and 7 (HHV-7) | Herpesvirus | • Identified HHV-6 and HHV-7 in late-onset AD patients (Readhead et al., 2018) • Reduced autophagy, promoted accumulation of hyperphosphorylated Tau and Aβ peptides (Romeo et al., 2020) • Infected microglia enhanced Aβ peptide deposition and Tau phosphorylation (Bortolotti et al., 2019) |
|
Herpes simplex virus 1 (HSV-1) | Herpesvirus | • Found HSV-1 antibodies in female AD patients over 60 years of age (Lövheim et al., 2015a) • Detected HSV-1 DNA in the brains of AD patients (Wozniak et al., 2009b) • Increased β-amyloidosis as an antimicrobial defense mechanism, which increased senile plaque formation (Eimer et al., 2018) • Promoted Tau hyperphosphorylation and damage in primary neurons (Zambrano et al., 2008) |
|
Human immunodeficiency virus (HIV-1) | Retrovirus | • Inhibited Aβ degradation in human brain cultures (Rempel and Pulliam, 2005) • Promoted cleavage of APP into Aβ peptides (Kim et al., 2013; Hategan et al., 2017) • Promoted Tau hyperphosphorylation and NFT deposition (Giunta et al., 2009). • Enhanced pro-inflammatory cytokine secretion from microglia, astrocytes, and monocytes (Nookala and Kumar, 2014; Haij et al., 2015; Liu and Kumar, 2015) • Activated immune signaling pathways (Herbein and Khan, 2008; Herbein, 2016) • Promoted Aβ secretion from primary hippocampal neurons (Aksenov et al., 2010) • Inhibited apoptosis in infected human neuroblastoma cells (Thomas et al., 2009) • Increased trafficking of Aβ to neural progenitor cells (András et al., 2017, 2020) • Detected elevated hyperphosphorylated Tau in the hippocampus of HIV-infected patients (Anthony et al., 2006) |
|
Human T cell leukemia virus type I (HTLV-1) | Retrovirus | • Increased activation of Tau kinases, increased Tau phosphorylation in vitro (Maldonado et al., 2011) | |
Parkinson’s disease (PD) | Helicobacter pylori | Gram-negative bacteria | • Found in PD patients in high prevalence (Huang et al., 2018; McGee et al., 2018) • Improved motor functions in patients who have cleared H. pylori infection (Lahner et al., 2009; Huang et al., 2018) |
Hepatitis C virus (HCV) | Flavivirus | • Increased neuronal death (Weissenborn et al., 2006; Abushouk et al., 2017; Wijarnpreecha et al., 2018) • Increased production of pro-inflammatory cytokines and chemokines from activated microglia (Lyons and Benveniste, 1998; Wu et al., 2015; Abushouk et al., 2017) |
|
Human immunodeficiency virus (HIV-1) | Retrovirus | • Infected dopaminergic neurons and associated with development of dementia (Nath et al., 2000) | |
Cytomegalovirus (CMV) | Herpesvirus | • Elevated levels of circulating pro-inflammatory myeloid cells found in PD patients (Goldeck et al., 2016) | |
Theiler’s murine encephalomyelitis virus (TMEV) | Picornavirus | • Infected dopaminergic neurons in vivoand promoted neurodegeneration (Oliver et al., 1997) | |
Japanese Encephalitis virus (JEV) | Flavivirus | • Infected dopaminergic neurons, modulated dopamine signaling, promoted neurodegeneration (Simanjuntak et al., 2017) | |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | Coronavirus | • Detected viral RNA and evidence of microglia activation and T lymphocyte infiltration in the post-mortem brain of COVID-19 patients (Matschke et al., 2020) | |
Amyotrophic lateral sclerosis (ALS) | Human immunodeficiency virus (HIV-1) | Retrovirus | • Reduced glutamate transport and increased neuronal excitotoxicity in infected human astrocytes in vitro (Wang et al., 2003) • Increased production and mislocalization of Fus in iPSC-derived spinal neurons (Bellmann et al., 2019) • Promoted axonal degeneration (Berth et al., 2016) |
Human endogenous retrovirus K (HERV-K) | Retrovirus | • Regulated activation of TDP-43 (Li et al., 2015) | |
Theiler’s murine encephalomyelitis virus (TMEV) | Picornavirus | • Promoted TDP-43 phosphorylation, mislocalization, and aggregation following infection in vitroandin vivo(Masaki et al., 2019) | |
Rabies virus (RABV) | Rhabdovirus | • Increased production and mislocalization of Fus in iPSC-derived spinal neurons (Bellmann et al., 2019) |